Efonidipine, another beauty relieving the pressure.
作者信息
Shin Jinho
机构信息
Division of Cardiology, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
出版信息
Korean Circ J. 2012 Apr;42(4):229-30. doi: 10.4070/kcj.2012.42.4.229. Epub 2012 Apr 26.
Abstract
摘要
相似文献
1
Efonidipine, another beauty relieving the pressure.依福地平，又一款降压良药。
Korean Circ J. 2012 Apr;42(4):229-30. doi: 10.4070/kcj.2012.42.4.229. Epub 2012 Apr 26.
2
Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury.新型钙拮抗剂盐酸依福地平对伴有肾小球损伤的自发性高血压大鼠的肾脏影响。
Clin Exp Pharmacol Physiol. 1999 Sep;26(9):674-9. doi: 10.1046/j.1440-1681.1999.03114.x.
3
Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.盐酸依福地平对应激所致心率及循环变化的影响。
Clin Exp Hypertens. 2009 Feb;31(1):83-91. doi: 10.1080/10641960802627363.
4
Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.依福地平可降低慢性肾小球肾炎患者的蛋白尿和血浆醛固酮水平。
Hypertens Res. 2007 Jul;30(7):621-6. doi: 10.1291/hypres.30.621.
5
Effect of efonidipine, a novel dihydropyridine derivative, on myocardial metabolic changes induced by coronary artery ligation in dogs: comparison with nifedipine.
Fundam Clin Pharmacol. 1997;11(3):245-51. doi: 10.1111/j.1472-8206.1997.tb00192.x.
6
Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.依福地平治疗对原发性高血压患者血浆醛固酮及左心室质量指数的长期影响。
Hypertens Res. 2009 Aug;32(8):670-4. doi: 10.1038/hr.2009.78. Epub 2009 Jun 5.
7
Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.T型钙通道抑制剂盐酸埃福地平和交感神经活动的临床疗效
Circ J. 2003 Feb;67(2):139-45. doi: 10.1253/circj.67.139.
8
[Effect of efonidipine hydrochloride (NZ-105), a dihydropyridine derivative with calcium antagonistic action, on myocardial oxygen tension in anesthetized dogs].
Nihon Yakurigaku Zasshi. 1996 Nov;108(5):267-74. doi: 10.1254/fpj.108.267.
9
[Effect of efonidipine hydrochloride on myocardial oxygen balance in anesthetized dogs].
Nihon Yakurigaku Zasshi. 1996 Aug;108(2):39-48. doi: 10.1254/fpj.108.39.
10
Structural basis for efonidipine block of a voltage-gated Ca channel.电压门控钙通道中依福地平阻滞的结构基础。
Biochem Biophys Res Commun. 2019 Jun 4;513(3):631-634. doi: 10.1016/j.bbrc.2019.03.176. Epub 2019 Apr 10.
本文引用的文献
1
Effect of an L- and T-type calcium channel blocker on 24-hour systolic blood pressure and heart rate in hypertensive patients.L 型和 T 型钙通道阻滞剂对高血压患者 24 小时收缩压和心率的影响。
Korean Circ J. 2012 Apr;42(4):231-8. doi: 10.4070/kcj.2012.42.4.231. Epub 2012 Apr 26.
2
Beneficial Effect of Efonidipine, an L- and T-Type Dual Calcium Channel Blocker, on Heart Rate and Blood Pressure in Patients With Mild-to-Moderate Essential Hypertension.依福地平（L-及 T-型钙通道双重阻滞剂）对轻中度原发性高血压患者心率及血压的有益影响。
Korean Circ J. 2010 Oct;40(10):514-9. doi: 10.4070/kcj.2010.40.10.514. Epub 2010 Oct 31.
3
Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.T 型和 L 型钙通道阻滞剂依福地平对 2 型糖尿病伴高血压肾病患者肾功能和动脉僵硬度的保护作用。
J Atheroscler Thromb. 2009 Oct;16(5):568-75. doi: 10.5551/jat.1628. Epub 2009 Sep 14.
4
Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate.心率对中心主动脉压和血流动力学的影响：来自CAFE（导管动脉功能评估）研究：CAFE-心率分析
J Am Coll Cardiol. 2009 Aug 18;54(8):705-13. doi: 10.1016/j.jacc.2009.02.088.
5
Heart rate as a treatable cardiovascular risk factor.心率作为一种可治疗的心血管危险因素。
Br Med Bull. 2009;90:71-84. doi: 10.1093/bmb/ldp016. Epub 2009 May 27.
6
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.伊伐布雷定用于稳定型冠状动脉疾病和左心室收缩功能障碍患者（BEAUTIFUL）：一项随机、双盲、安慰剂对照试验。
Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.
7
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.盎格鲁-斯堪的纳维亚心脏结局试验-降压分支（ASCOT-BPLA）：氨氯地平降压方案按需加用培哚普利与阿替洛尔按需加用苄氟噻嗪预防心血管事件的多中心随机对照试验
Lancet. 2005;366(9489):895-906. doi: 10.1016/S0140-6736(05)67185-1.
8
Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.盐酸依福地平：L型和T型钙（2+）通道的双重阻滞剂。
Cardiovasc Drug Rev. 2002 Winter;20(1):81-92. doi: 10.1111/j.1527-3466.2002.tb00084.x.
Zotero 插件